Harvest Technologies Corporation

Lou Blasetti

John R Wells

Wesley H Verkaart

Steven Michael Gann

Mark L Kibbe

Russell Hart

Ali Faghani Azimpoor

Lin A Jakary, Legal Representative

Sherwin V Kevy

Devices for extracting bone marrow from a bone of a patient are disclosed. The device includes a housing defined in part by a cannula and a hollow needle disposed within the cannula. The hollow needle is movable axially relative to the cannula and extendable therefrom. The hollow needle is configured to aspirate bone marrow within a bone. A depth adjustment mechanism coupled to the hollow needle and the cannula is used to adjust the depth of the hollow needle relative to the cannula to control the distance of the needle within the bone. The device is attachable to an extraction device to extract bone marrow from the patient through the hollow needle. Methods of using these devices and methods of extracting bone marrow are also included.

Bone marrow aspiration device and needle

A method, and apparatus for transferring a fluid to a sterile field includes the use of a sterile enclosure () housing a syringe (). The enclosure () is made in two parts, and allows the syringe () to be operated while it is in the enclosure. When it is desired to pass the fluids to the sterile field, the enclosure is separated into at least two parts to allow the syringe to be removed. This removal of the syringe is done such that the user in the non-sterile field does not touch the syringe. Thus, the syringe, and fluid therein are easily transferred to the sterile field.

Apparatus for the sterile transfer of fluids

Platelet rich plasma and/or platelet concentrate is prepared by placing whole blood in a first chamber of a sterile processing disposable having two chambers. The processing disposable is subjected to a first centrifugation to separate red blood cells, and the resulting platelet rich plasma supernatant is decanted to the second chamber. The processing disposable is subjected to a second centrifugation to concentrate platelets. A volume of the platelet poor plasma supernatant in the second chamber is removed, and the platelets are re-suspended in the remaining plasma. The second chamber may contain anticoagulant to preclude aggregation of the platelets.

Method for producing platelet rich plasma and/or platelet concentrate

Growing community of inventors

North Quincy, MA, United States of America

Lou Blasetti